IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0026864.html
   My bibliography  Save this article

Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in Iran

Author

Listed:
  • Mehdi Javanbakht
  • Hamid R Baradaran
  • Atefeh Mashayekhi
  • Ali Akbar Haghdoost
  • Mohammad E Khamseh
  • Erfan Kharazmi
  • Aboozar Sadeghi

Abstract

Introduction: Diabetes is a worldwide high prevalence chronic progressive disease that poses a significant challenge to healthcare systems. The aim of this study is to provide a detailed economic burden of diagnosed type 2 diabetes mellitus (T2DM) and its complications in Iran in 2009 year. Methods: This is a prevalence-based cost-of-illness study focusing on quantifying direct health care costs by bottom-up approach. Data on inpatient hospital services, outpatient clinic visits, physician services, drugs, laboratory test, education and non-medical cost were collected from two national registries. The human capital approach was used to calculate indirect costs separately in male and female and also among different age groups. Results: The total national cost of diagnosed T2DM in 2009 is estimated at 3.78 billion USA dollars (USD) including 2.04±0.28 billion direct (medical and non-medical) costs and indirect costs of 1.73 million. Average direct and indirect cost per capita was 842.6±102 and 864.8 USD respectively. Complications (48.9%) and drugs (23.8%) were main components of direct cost. The largest components of medical expenditures attributed to diabetes's complications are cardiovascular disease (42.3% of total Complications cost), nephropathy (23%) and ophthalmic complications (14%). Indirect costs include temporarily disability (335.7 million), permanent disability (452.4 million) and reduced productivity due to premature mortality (950.3 million). Conclusions: T2DM is a costly disease in the Iran healthcare system and consume more than 8.69% of total health expenditure. In addition to these quantified costs, T2DM imposes high intangible costs on society in terms of reduced quality of life. Identification of effective new strategies for the control of diabetes and its complications is a public health priority.

Suggested Citation

  • Mehdi Javanbakht & Hamid R Baradaran & Atefeh Mashayekhi & Ali Akbar Haghdoost & Mohammad E Khamseh & Erfan Kharazmi & Aboozar Sadeghi, 2011. "Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in Iran," PLOS ONE, Public Library of Science, vol. 6(10), pages 1-7, October.
    • Handle: RePEc:plo:pone00:0026864
    DOI: 10.1371/journal.pone.0026864
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0026864
    Download Restriction: no
    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0026864&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pone.0026864?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Molina, Begoña & Monereo, Susana, 2003. "Direct healthcare costs of diabetes mellitus patients in Spain," UC3M Working papers. Economics we036827, Universidad Carlos III de Madrid. Departamento de Economía.
    2. John Posnett & Stephen Jan, 1996. "Indirect cost in economic evaluation: The opportunity cost of unpaid inputs," Health Economics, John Wiley & Sons, Ltd., vol. 5(1), pages 13-23, January.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Si Thu Win Tin & George Iro & Eva Gadabu & Ruth Colagiuri, 2015. "Counting the Cost of Diabetes in the Solomon Islands and Nauru," PLOS ONE, Public Library of Science, vol. 10(12), pages 1-13, December.
    2. Mehdi Javanbakht & Atefeh Mashayekhi & Hamid R Baradaran & AliAkbar Haghdoost & Ashkan Afshin, 2015. "Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis," PLOS ONE, Public Library of Science, vol. 10(7), pages 1-17, July.
    3. Tien Thanh, Pham & Bao Duong, Pham, 2022. "The economic burden of non-communicable diseases on households and their coping mechanisms: Evidence from rural Vietnam," World Development, Elsevier, vol. 151(C).
    4. Muhammad Daoud Butt & Siew Chin Ong & Muhammad Umar Wahab & Muhammad Fawad Rasool & Fahad Saleem & Adnan Hashmi & Ahsan Sajjad & Furqan Aslam Chaudhry & Zaheer-Ud-Din Babar, 2022. "Cost of Illness Analysis of Type 2 Diabetes Mellitus: The Findings from a Lower-Middle Income Country," IJERPH, MDPI, vol. 19(19), pages 1-15, October.
    5. Shamal Shivneel Chand & Baljeet Singh & Sanjesh Kumar, 2020. "The economic burden of non-communicable disease mortality in the South Pacific: Evidence from Fiji," PLOS ONE, Public Library of Science, vol. 15(7), pages 1-18, July.
    6. Charmaine Shuyu Ng & Matthias Paul Han Sim Toh & Yu Ko & Joyce Yu-Chia Lee, 2015. "Direct Medical Cost of Type 2 Diabetes in Singapore," PLOS ONE, Public Library of Science, vol. 10(3), pages 1-11, March.
    7. Rahill Sadat Shahtaheri & Yahya Bayazidi & Majid Davari & Abbas Kebriaeezadeh & Sepideh Yousefi & Alireza Mahdavi Hezaveh & Abolfazl Sadeghi & Ahmed Hayder Mohsin Lami & Hadi Abbasian, 2022. "Long-term cost-effectiveness of quality of diabetes care; experiences from private and public diabetes centers in Iran," Health Economics Review, Springer, vol. 12(1), pages 1-7, December.
    8. Lan Gao & Hao Hu & Fei-Li Zhao & Shu-Chuen Li, 2016. "Can the Direct Medical Cost of Chronic Disease Be Transferred across Different Countries? Using Cost-of-Illness Studies on Type 2 Diabetes, Epilepsy and Schizophrenia as Examples," PLOS ONE, Public Library of Science, vol. 11(1), pages 1-17, January.
    9. Hedyeh Ebrahimi & Farhad Pishgar & Moein Yoosefi & Sedighe Moradi & Nazila Rezaei & Shirin Djalalinia & Mitra Modirian & Niloofar Peykari & Shohreh Naderimagham & Rosa Haghshenas & Saral Rahimi & Hami, 2019. "Insulin pen use and diabetes treatment goals: A study from Iran STEPS 2016 survey," PLOS ONE, Public Library of Science, vol. 14(8), pages 1-12, August.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. McDonald, Rebecca & Powdthavee, Nattavudh, 2018. "The Shadow Prices of Voluntary Caregiving: Using Panel Data of Well-Being to Estimate the Cost of Informal Care," IZA Discussion Papers 11545, Institute of Labor Economics (IZA).
    2. Wilkinson-Meyers, Laura & Brown, Paul & McNeill, Robert & Patston, Philip & Dylan, Sacha & Baker, Ronelle, 2010. "Estimating the additional cost of disability: Beyond budget standards," Social Science & Medicine, Elsevier, vol. 71(10), pages 1882-1889, November.
    3. Joan Costa‐Font & Cristina Vilaplana‐Prieto, 2025. "The Hidden Value of Adult Informal Care in Europe," Health Economics, John Wiley & Sons, Ltd., vol. 34(4), pages 791-812, April.
    4. Cameron Morgan & Cam Donaldson & Emily Lancsar & Stavros Petrou & Lazaros Andronis, 2024. "Considerations Around the Inclusion of Children and Young People’s Time in Economic Evaluation: Findings from an International Delphi Study," PharmacoEconomics, Springer, vol. 42(11), pages 1267-1277, November.
    5. Andronis, Lazaros & Maredza, Mandy & Petrou, Stavros, 2019. "Measuring, valuing and including forgone childhood education and leisure time costs in economic evaluation: Methods, challenges and the way forward," Social Science & Medicine, Elsevier, vol. 237(C), pages 1-1.
    6. Tatiana Dilla & Amparo Valladares & Claudia Nicolay & Javier Salvador & Jesús Reviriego & María Costi, 2012. "Healthcare Costs Associated with Change in Body Mass Index in Patients with Type 2 Diabetes Mellitus in Spain," Applied Health Economics and Health Policy, Springer, vol. 10(6), pages 417-430, November.
    7. Berta Rivera & Bruno Casal & Luis Currais, 2008. "Estudio económico del tiempo de cuidado informal como factor de producción de salud en el enfermo de Alzheimer no institucionalizado," Economic Reports 16-08, FEDEA.
    8. Till Seuring & Olga Archangelidi & Marc Suhrcke, 2015. "The Economic Costs of Type 2 Diabetes: A Global Systematic Review," PharmacoEconomics, Springer, vol. 33(8), pages 811-831, August.
    9. Bernard van den Berg & Ada Ferrer-i-Carbonell, 2007. "Monetary valuation of informal care: the well-being valuation method," Health Economics, John Wiley & Sons, Ltd., vol. 16(11), pages 1227-1244.
    10. Juan Oliva-Moreno & Julio López-Bastida & Rubén Osuna-Guerrero & Angel Montejo-González & Beatriz Duque-González, 2006. "The costs of schizophrenia in Spain," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 7(3), pages 179-184, September.
    11. Costa-Font, Joan & Vilaplana-Prieto, Cristina, 2025. "The hidden value of adult informal care in Europe," LSE Research Online Documents on Economics 126347, London School of Economics and Political Science, LSE Library.
    12. Bernard van denBerg & Werner Brouwer & Job van Exel & Marc Koopmanschap, 2005. "Economic valuation of informal care: the contingent valuation method applied to informal caregiving," Health Economics, John Wiley & Sons, Ltd., vol. 14(2), pages 169-183, February.
    13. Tokunaga, Mutsumi & Hashimoto, Hideki, 2017. "The socioeconomic within-gender gap in informal caregiving among middle-aged women: Evidence from a Japanese nationwide survey," Social Science & Medicine, Elsevier, vol. 173(C), pages 48-53.
    14. Hassink, Wolter H.J. & Van den Berg, Bernard, 2011. "Time-bound opportunity costs of informal care: Consequences for access to professional care, caregiver support, and labour supply estimates," Social Science & Medicine, Elsevier, vol. 73(10), pages 1508-1516.
    15. Mark Burkey, 2012. "Decomposing geographic accessibility into component parts: methods and an application to hospitals," The Annals of Regional Science, Springer;Western Regional Science Association, vol. 48(3), pages 783-800, June.
    16. David Nathanson & Ugne Sabale & Jan W. Eriksson & Thomas Nyström & Anna Norhammar & Urban Olsson & Johan Bodegård, 2018. "Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006–2014," PharmacoEconomics - Open, Springer, vol. 2(4), pages 393-402, December.
    17. Stevens Azima & Patrick Mundler, 2023. "Farmer satisfaction and short food supply chains," Agriculture and Human Values, Springer;The Agriculture, Food, & Human Values Society (AFHVS), vol. 40(4), pages 1531-1536, December.
    18. E. Michael Foster & Michele M. Porter & Tim S. Ayers & Debra L. Kaplan & Irwin Sandler, 2007. "Estimating the Costs of Preventive Interventions," Evaluation Review, , vol. 31(3), pages 261-286, June.
    19. Simone Gerzeli & Aleksandra Torbica & Giovanni Fattore, 2009. "Cost utility analysis of knee prosthesis with complete microprocessor control (C-leg) compared with mechanical technology in trans-femoral amputees," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 10(1), pages 47-55, February.
    20. Voordouw, Jantine & Antonides, Gerrit & Fox, Margaret & Cerecedo, Inma & Zamora, Javier & Frewer, Lynn J., 2016. "The Direct And Indirect Costs Associated With Food Hypersensitivity In Households: A Study In The Netherlands, Poland, And Spain," APSTRACT: Applied Studies in Agribusiness and Commerce, AGRIMBA, vol. 10(2-3), pages 1-12, October.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0026864. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.